The recent disruptions in global supply have highlighted the importance of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes regions to potential vulnerabilities, including transportation delays, cost fluctuations, and even geopolitical risks. Shifting towards domestic procurement of Ivermectin offers a multi